{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:10:22Z","timestamp":1746159022496,"version":"3.40.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.7759\/cureus.83299","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:31:50Z","timestamp":1746109910000},"source":"Crossref","is-referenced-by-count":0,"title":["Interdisciplinary Approach to Diagnostic Challenges: A Case Study of Cardiac Amyloid Light-Chain (AL) Amyloidosis, Multiple Myeloma, and Ductal Carcinoma In Situ"],"prefix":"10.7759","author":[{"given":"Yuko","family":"Tashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0250-0","article-title":"Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium","volume":"32","author":"Lousada I","year":"2015","unstructured":"Lousada I, Comenzo RL, Landau H, Guthrie S, Merlini G. Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium. Adv Ther. 2015, 32:920-8. 10.1007\/s12325-015-0250-0","journal-title":"Adv Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0159","article-title":"Amyloidosis\u2014the diagnosis and treatment of an underdiagnosed disease","volume":"117","author":"Ihne S","year":"2020","unstructured":"Ihne S, Morbach C, Sommer C, Geier A, Knop S, St\u00f6rk S. Amyloidosis\u2014the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int. 2020, 117:159-66. 10.3238\/arztebl.2020.0159","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27177","article-title":"Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment","volume":"99","author":"Gertz MA","year":"2024","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. Am J Hematol. 2024, 99:309-24. 10.1002\/ajh.27177","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis E","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC, et al.. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med. 2021, 385:46-58. 10.1056\/NEJMoa2028631","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle RA","year":"2004","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004, 351:1860-73. 10.1056\/NEJMra041875","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1028-8","article-title":"Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature","volume":"90","author":"Siragusa S","year":"2011","unstructured":"Siragusa S, Morice W, Gertz MA, et al.. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature. Ann Hematol. 2011, 90:101-6. 10.1007\/s00277-010-1028-8","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk RH","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997, 337:898-909. 10.1056\/NEJM199709253371306","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk RH","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol. 2016, 68:1323-41. 10.1016\/j.jacc.2016.06.053","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9206-17","article-title":"Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan","volume":"57","author":"Shimazaki C","year":"2018","unstructured":"Shimazaki C, Hata H, Iida S, et al.. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med. 2018, 57:181-7. 10.2169\/internalmedicine.9206-17","journal-title":"Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-0535","article-title":"International variation in female breast cancer incidence and mortality rates","volume":"24","author":"DeSantis CE","year":"2015","unstructured":"DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2015, 24:1495-506. 10.1158\/1055-9965.EPI-15-0535","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2024.10.036","article-title":"Breast Imaging: what women & healthcare professionals need to know","volume":"54","author":"Seely JM","year":"2025","unstructured":"Seely JM, Doherty A, Bissell MB. Breast Imaging: what women & healthcare professionals need to know. Curr Probl Diagn Radiol. 2025, 54:51-64. 10.1067\/j.cpradiol.2024.10.036","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/17539447231216318","article-title":"The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis","volume":"17","author":"Kwok CS","year":"2023","unstructured":"Kwok CS, Moody WE. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis. Ther Adv Cardiovasc Dis. 2023, 17:17539447231216318. 10.1177\/17539447231216318","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar AD","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016, 387:2641-54. 10.1016\/S0140-6736(15)01274-X","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, et al.. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021, 42:1554-68. 10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004460","article-title":"Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA","volume":"136","author":"Palladini G","year":"2020","unstructured":"Palladini G, Kastritis E, Maurer MS, et al.. Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA. Blood. 2020, 136:71-80. 10.1182\/blood.2019004460","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death","volume":"129","author":"Muchtar E","year":"2017","unstructured":"Muchtar E, Gertz MA, Kumar SK, et al.. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death. Blood. 2017, 129:2111-9. 10.1182\/blood-2016-11-751628","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353647-interdisciplinary-approach-to-diagnostic-challenges-a-case-study-of-cardiac-amyloid-light-chain-al-amyloidosis-multiple-myeloma-and-ductal-carcinoma-in-situ","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:31:51Z","timestamp":1746109911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353647-interdisciplinary-approach-to-diagnostic-challenges-a-case-study-of-cardiac-amyloid-light-chain-al-amyloidosis-multiple-myeloma-and-ductal-carcinoma-in-situ"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.83299","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}